Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Value of Biological Age, in Addition to Individual Frailty, for Personalising the Management of Cancer Treated with Targeted Therapy: the Model of Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors.

NCT06130787 is registered in ClinicalTrials.gov with University Hospital, Clermont-Ferrand as lead sponsor.

NCT NCT06130787
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06130787 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Value of Biological Age, in Addition to Individual Frailty, for Personalising the Management of Cancer Treated with Targeted Therapy: the Model of Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors.
Lead sponsor
University Hospital, Clermont-Ferrand
Phase
Not applicable
Overall status
Recruiting
Start date
November 17, 2023
Completion date
November 17, 2028
Enrollment
321 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia,myeloid, chronic